Skip to content

The protective effect of ischemic preconditioning induced by acute isovolumetric hemodilution via radial artery on patients undergoing hepatectomy

The protective effect of ischemic preconditioning induced by acute isovolumetric hemodilution via radial artery on patients undergoing hepatectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048024
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-07-06
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver ischemia reperfusion injury

Interventions

Ischemic preconditioning group:Acute isovolumetric hemodilution via radial artery causes ischemic preconditioning
Control group:Acute isovolumetric hemodilution via the internal jugular vein without ischemic preconditioning

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing hepatectomy under general anesthesia with tracheal intubation, hepatic portal blockade during the operation and low central venous pressure is required; 2. ASA classification is I to III; 3. Positive bilateral Allen test: less than 10s; 4. Aged 18 to 70 years old; 5. Body mass index (BMI): 18.5kg/m2-30.0kg/m2.

Exclusion criteria

Exclusion criteria: 1. Combined with severe liver and kidney dysfunction (alanine aminotransferase>50U/L, aspartate aminotransferase>50U/L; blood creatinine>200µmol/L, blood urea nitrogen>9mmoml/L); 2. Preoperative anemia: male hemoglobin <100g/L, female hemoglobin <90 g/L; 3. Abnormal coagulation function: prothrombin time: PT=17.3 seconds; plasma partial thromboplastin time: APTT=50 seconds; fibrinogen FIB=1.5g/L; platelet PLT=100 x 109/L; 4. Patients infected at the puncture site; 5. Patients who cannot cooperate with the study for any reason.

Design outcomes

Primary

MeasureTime frame
Alanine aminotransferase;Aspartate aminotransferase;

Secondary

MeasureTime frame
Bilirubin;Blood perfusion index;

Countries

China

Contacts

Public ContactTang Jing

Affiliated Hospital of Guangdong Medical University

tanglitangjing@126.com+86 13189091282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026